Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
26.74
-0.38 (-1.40%)
At close: Apr 28, 2026, 4:00 PM EDT
26.72
-0.02 (-0.07%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Oculis Holding AG Employees
Oculis Holding AG had 60 employees as of December 31, 2025. The number of employees increased by 11 or 22.45% compared to the previous year.
Employees
60
Change (1Y)
11
Growth (1Y)
22.45%
Revenue / Employee
$25,201
Profits / Employee
-$2,079,934
Market Cap
1.58B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60 | 11 | 22.45% |
| Dec 31, 2024 | 49 | 13 | 36.11% |
| Dec 31, 2023 | 36 | 8 | 28.57% |
| Dec 31, 2022 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 711 |
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Biohaven | 274 |
| Monte Rosa Therapeutics | 150 |
| Nanobiotix | 103 |
| Bicara Therapeutics | 103 |
OCS News
- 7 days ago - Oculis Publishes Invitation to the Annual General Meeting - GlobeNewsWire
- 8 days ago - Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema - GlobeNewsWire
- 14 days ago - Oculis Holding AG Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewsWire
- 21 days ago - Oculis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis - GlobeNewsWire
- 6 weeks ago - Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting - GlobeNewsWire
- 7 weeks ago - Oculis Holding AG Transcript: Leerink Global Healthcare Conference 2026 - Transcripts